Biochem/physiol Actions
Angiotensin converting enzyme (ACE) inhibitor.
Features and Benefits
This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
- UPC:
- 51141518
- Condition:
- New
- HazmatClass:
- No
- MPN:
- R0404-100MG
- CAS:
- 87333-19-5
akash.verma@cenmed.com
(732) 447-1115





